Opexa Therapeutics Inc. (OPXA) Rating Reiterated by Chardan Capital


's stock had its "neutral" rating reiterated by equities research analysts at Chardan Capital in a research report issued to clients and investors on Friday. Several other brokerages have also recently issued reports on OPXA.



from Biotech News